NCT03763396View on ClinicalTrials.gov

Azoles Targeting Recurrent High Grade Gliomas

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2027

Conditions
Brain Tumor, RecurrentCancer, AdvancedGlioma of Brain
Interventions
DRUG

Ketoconazole (KCZ)

Oral Tablet

DRUG

Posaconazole (PCZ)

Delayed Release Oral Tablet

Trial Locations (1)

M5T 2S8

Toronto Western Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT03763396 - Azoles Targeting Recurrent High Grade Gliomas | Biotech Hunter | Biotech Hunter